Clin2
NCT07804615Possibly a fitRecruiting

Investigational drug for tremor from Parkinson's disease

PARKINSON DISEASE (Disorder)

Part of Brain & nervous system clinical trials.

This study is testing an investigational drug for Parkinson's-related tremor (shaking). It aims to see if the drug can help reduce tremor in people whose symptoms are not fully controlled by current treatment.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
80 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You are 18 to 65 years old.
  • You have been diagnosed with Parkinson's disease and tremor (shaking) is a primary symptom.
  • If you take Parkinson's medication, your dose has been stable for at least 10 weeks. OR You are not currently taking any Parkinson's medication and never have.
  • You have not had any previous brain surgery for Parkinson's.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07822893Not yet recruiting· Phase 3
BoNT-A injections for shaking in Parkinson's disease

This trial tests whether botulinum toxin type A injections can reduce shaking (tremor) in the hand or arm that does not improve with standard Parkinson's medications. It aims to see if this treatment can provide relief for people with difficult-to-control tremor.

Nîmes
NCT07422675Recruiting· Phase 1
Study of a new treatment for Parkinson's with motor fluctuations

This study tests a new single-dose treatment for Parkinson's disease to see if it can help reduce 'off' time—when medication wears off and symptoms return. It is for people who experience motor fluctuations and are already on a stable medication routine.

Englewood, Colorado
NCT07074002Recruiting· Phase 2
Study of a new drug for essential tremor

This trial tests a new study drug (BP1.4979) to see if it can reduce shaking in people with essential tremor. It's for people who have had arm tremors for at least 3 years and have not had surgery for tremor.

Amiens
NCT07781644Not yet recruiting· Phase 1/Phase 2
Testing a new drug for early Parkinson's disease

This trial tests an experimental drug called RO7568282 to see if it is safe and can help with early Parkinson's disease symptoms. It is for people who have been taking a stable dose of levodopa alone for at least two months.

NCT07725562Recruiting· Phase 2/Phase 3
VG081821AC tablets for early to mid-stage Parkinson's disease

This trial tests a new oral medication, VG081821AC, in people with early to mid-stage Parkinson's disease. The goal is to see if it can improve movement symptoms and slow the progression of the condition, and it may offer a new treatment option for those not yet on levodopa.

Beijing
NCT07134634Recruiting
Vibrating therapy ball for tremor relief

This trial tests whether a vibrating ball can help reduce tremor and make daily tasks easier. It is for people with different types of tremor, as long as they don't have major thinking problems or certain other health issues.

Beelitz, Brandenburg

Hear when a new PARKINSON DISEASE (Disorder) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.